Author:
Kontopodis E.,Kentepozidis N.,Christophyllakis Ch.,Boukovinas I.,Kalykaki A.,Kalbakis K.,Vamvakas L.,Agelaki S.,Kotsakis A.,Vardakis N.,Georgoulias V.,Mavroudis D.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference35 articles.
1. Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P (2005) Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 104(8):1742–1750. doi: 10.1002/cncr.21359
2. Vogel CL, Azevedo S, Hilsenbeck S, East DR, Ayub J (1992) Survival after first recurrence of breast cancer. The Miami experience. Cancer 70(1):129–135
3. Hayes DF, Henderson IC, Shapiro CL (1995) Treatment of metastatic breast cancer: present and future prospects. Semin Oncol 22 (2 Suppl 5):5–19; discussion 19–21
4. Vogel CL (1996) Current status of salvage chemotherapy for refractory advanced breast cancer. Oncology (Williston Park) 10(Suppl 6):7–15
5. Bissery MC, Guenard D, Gueritte-Voegelein F, Lavelle F (1991) Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51(18):4845–4852
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献